Medications for Wolffparkinsonwhite Syndrome

34 results
Skyepharma Production SAS
Usage: Betapace/Betapace AF is indicated for treating life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia, and for delaying recurrence of highly symptomatic atrial fibrillation/atrial flutter in patients currently in sinus rhythm. It is not intended for patients with easily reversible paroxysmal atrial fibrillation.
Ranbaxy Pharmaceuticals Inc.
Usage: Flecainide is indicated for the prevention of paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. It also treats documented life-threatening ventricular arrhythmias, but it is contraindicated in post-myocardial infarction patients and not recommended for chronic atrial fibrillation.
Bryant Ranch Prepack
Usage: Flecainide Acetate Tablets USP are indicated for preventing paroxysmal supraventricular tachycardias (PSVT) and paroxysmal atrial fibrillation/flutter (PAF) with disabling symptoms, as well as documented life-threatening sustained ventricular tachycardia. Not recommended for patients with recent myocardial infarction or less severe ventricular arrhythmias.
Bryant Ranch Prepack
Usage: Flecainide Acetate Tablets USP are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. They are also used for documented life-threatening sustained ventricular tachycardia. Use is not recommended in patients with recent myocardial infarction or less severe ventricular arrhythmias.
Amneal Pharmaceuticals LLC
Usage: Flecainide is indicated for preventing paroxysmal supraventricular tachycardias (PSVT) and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. It is also used for documented life-threatening ventricular arrhythmias. Its use is contraindicated in patients with recent myocardial infarction and chronic atrial fibrillation is not recommended.
Bryant Ranch Prepack
Usage: Flecainide Acetate Tablets are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. They are also used for life-threatening sustained ventricular tachycardia. The drug should not be used in patients with recent myocardial infarction or chronic atrial fibrillation.
Bryant Ranch Prepack
Usage: Flecainide acetate tablets are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease, as well as life-threatening ventricular arrhythmias. Their use is not recommended for patients with recent myocardial infarction or chronic atrial fibrillation.
A-S Medication Solutions
Usage: Flecainide acetate tablets are indicated for preventing paroxysmal supraventricular tachycardias (PSVT) and paroxysmal atrial fibrillation/flutter (PAF) with disabling symptoms, as well as life-threatening documented ventricular arrhythmias. Use in patients with recent myocardial infarction or chronic atrial fibrillation is not recommended.
Bryant Ranch Prepack
Usage: Flecainide acetate tablets are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. They're also used for documented, life-threatening sustained ventricular arrhythmias but should not be used post-myocardial infarction or for chronic atrial fibrillation.
HF Acquisition Co LLC, DBA HealthFirst
Usage: Lidocaine hydrochloride is indicated for the intravenous treatment of ventricular arrhythmias during cardiac procedures and for life-threatening ventricular arrhythmias, particularly during acute myocardial infarction.